These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7482735)

  • 1. The fate of renal allografts functioning for a minimum of 20 years (level 5A)--indefinite success or beginning of the end? A proposed classification of long-term allograft survivals.
    Braun WE; Popowniak KL; Nakamoto S; Gifford RW; Straffon RA
    Transplantation; 1995 Oct; 60(8):784-90. PubMed ID: 7482735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of initial slow graft function on renal allograft rejection and survival.
    Humar A; Johnson EM; Payne WD; Wrenshall L; Sutherland DE; Najarian JS; Gillingham KJ; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):623-7. PubMed ID: 9408697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
    Wu JY; Chen JH; Wang YM; Zhang JG; Zhu C; Wang SY; Zhang P; Huang HF; He Q
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):106-9. PubMed ID: 12812676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
    Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of race and ethnicity on kidney allograft outcome.
    Katznelson S; Gjertson DW; Cecka JM
    Clin Transpl; 1995; ():379-94. PubMed ID: 8794281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
    Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
    Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of gender and age matching for long-term graft survival in living donor renal transplantation.
    Kwon OJ; Kwak JY; Kang CM
    Transplant Proc; 2005 Mar; 37(2):726-8. PubMed ID: 15848514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
    Quiroga I; McShane P; Koo DD; Gray D; Friend PJ; Fuggle S; Darby C
    Nephrol Dial Transplant; 2006 Jun; 21(6):1689-96. PubMed ID: 16490743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?
    Frei U; Schindler R; Wieters D; Grouven U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1995; 10(7):1206-11. PubMed ID: 7478125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal allograft function and cardiovascular risk in recipients of kidney transplantation after successful pregnancy.
    Gutiérrez MJ; González P; Delgado I; Gutiérrez E; González E; Siqueira RC; Andrés A; Morales JM
    Transplant Proc; 2009; 41(6):2399-402. PubMed ID: 19715932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.